Oral VP-16-213 in advanced bronchogenic carcinoma.
D001855:Bone Marrow Diseases / Q000139:chemically induced*; D002283:Carcinoma, Bronchogenic / Q000188:drug therapy*; D004338:Drug Combinations; D005047:Etoposide / Q000009:adverse effects*; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D011034:Podophyllotoxin / Q000031:analogs & derivatives*; D014750:Vincristine / Q000009:adverse effects*
D004338:Drug Combinations; D014750:Vincristine; D005047:Etoposide; D011034:Podophyllotoxin